Schedule 13G ownership disclosure

APPLIED THERAPEUTICS INC

Common Stock · CUSIP: 03828A101

Event date: 2024-11-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • JANUS HENDERSON GROUP PLC

    Shares: 12,104,911 · Class: 10.4%

  • Janus Henderson Biotech Innovation Master Fund Ltd

    Shares: 6,201,300 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-24-000277
Form type
SCHEDULE 13G/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
Dec 06, 2024
Reporting period
Nov 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub